Cargando…
Mini-Review: The Administration of Apoptotic Cells for Treating Rheumatoid Arthritis: Current Knowledge and Clinical Perspectives
Rheumatoid arthritis (RA) is a chronic immune-mediated disease managed by conventional synthetic drugs, such as methotrexate (MTX), and targeted drugs including biological agents. Cell-based therapeutic approaches are currently developed in RA, mainly mesenchymal stroma cell-based approaches. Early-...
Autores principales: | Toussirot, Eric, Bonnefoy, Francis, Vauchy, Charline, Perruche, Sylvain, Saas, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7950318/ https://www.ncbi.nlm.nih.gov/pubmed/33717160 http://dx.doi.org/10.3389/fimmu.2021.630170 |
Ejemplares similares
-
Harnessing Apoptotic Cell Clearance to Treat Autoimmune Arthritis
por: Saas, Philippe, et al.
Publicado: (2017) -
Apoptotic cell infusion treats ongoing collagen-induced arthritis, even in the presence of methotrexate, and is synergic with anti-TNF therapy
por: Bonnefoy, Francis, et al.
Publicado: (2016) -
Resolution therapy: Harnessing efferocytic macrophages to trigger the resolution of inflammation
por: Saas, Philippe, et al.
Publicado: (2022) -
Could Sodium Chloride be an Environmental Trigger for Immune-Mediated Diseases? An Overview of the Experimental and Clinical Evidence
por: Toussirot, Eric, et al.
Publicado: (2018) -
Pro-Resolving Factor Administration Limits Cancer Progression by Enhancing Immune Response Against Cancer Cells
por: Wetzel, Audrey, et al.
Publicado: (2022)